Viewing Study NCT05471713



Ignite Creation Date: 2024-05-06 @ 5:54 PM
Last Modification Date: 2024-10-26 @ 2:37 PM
Study NCT ID: NCT05471713
Status: UNKNOWN
Last Update Posted: 2022-07-25
First Post: 2022-06-08

Brief Title: MAPT Haploid H1b and the Damage of BBB in Dorsal Medulla Oblongata and Autonomic Dysfunction in PD
Sponsor: Zhujiang Hospital
Organization: Zhujiang Hospital

Study Overview

Official Title: Study on the Correlation Between MAPT Haploid H1b and the Damage of Blood-brain Barrier in Dorsal Medulla Oblongata and Autonomic Dysfunction in Parkinsons Disease
Status: UNKNOWN
Status Verified Date: 2022-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study mainly explored the relationship between the permeability of the blood-brain barrier in the dorsal medulla oblongata and autonomic dysfunction and the relationship and mechanism of MAPT genotype on the permeability of the blood-brain barrier and the progression of autonomic dysfunction in PD patients
Detailed Description: According to the MDS 2015 clinical diagnostic criteria for Parkinsons disease and the diagnostic criteria for autonomic dysfunction AutD the patients were divided into PD with AutD group and PD without AutD group DCE results pet-pdrp18f-dopa data and clinical evaluation SCOPA-AUT HRV and sleep EEG were analyzed Blood samples were collected to detect MAPT gene polymorphism oligomers and phosphorylated synuclein To explore the relationship between the permeability of the blood-brain barrier in the dorsal medulla oblongata and autonomic dysfunction and the relationship and mechanism of MAPT genotype on the permeability of the blood-brain barrier and the progression of autonomic dysfunction in PD patients

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None